Hims & Hers, a well-known American e-pharmacy, has expanded its product offerings to include a weight-loss drug, joining the market for medications like Wegovy.

This expansion is made possible by a specific provision in U.S. law that permits pharmacies to create their own versions of certain brand-name drugs when there are shortages.

Analysts predict that Hims & Hers will generate around $145 million in revenue from its weight-loss drug this year, highlighting the increasing competition in the pharmaceutical industry to make weight-loss treatments more affordable and accessible.